Previous Close | 36.23 |
Open | 36.35 |
Bid | 35.51 x 1200 |
Ask | 36.80 x 1200 |
Day's Range | 35.78 - 36.22 |
52 Week Range | 34.76 - 56.02 |
Volume | |
Avg. Volume | 81,168 |
Market Cap | 683.025M |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 12.53 |
EPS (TTM) | 2.86 |
Earnings Date | Oct 22, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48.00 |
USANA Health Sciences, Inc. is proud to announce that the Prescribers' Digital Reference® (PDR) has recently included 11 of USANA's products to their list of trusted drugs and supplements. This recognition adds further credibility to the world-renowned quality of USANA's products while placing supplemental facts directly in the hands of prescribers.
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.